Rua Bioscience has announced a settlement with Cann Group, following legal proceedings initiated by Rua in February 2024.
The settlement was reached after both parties engaged in mediation.
As part of the agreement, Rua and Cann have signed new supply agreements to support their operations in the New Zealand and Australian medicinal cannabis markets.
The commercial terms of the settlement are confidential and will take effect immediately.
See more
